Dr. Abraham Palmer awarded NIAAA R01 grant

Dr. Abraham Palmer was awarded an R01 grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for his project titled “A Novel Pharmacotherapy for Alcoholism: Evaluation of Reward, Aversion, Compulsivity, Withdrawal & Reinstatement.” This is a five year grant that starts July 5, 2018 and ends April 30, 2023. This grant will fund a project to study how and why inhibitors of the enzyme GLO1 decrease ethanol drinking in mice and to develop GLO1 inhibitors for use as a therapy for alcohol use disorder.

Posted under: Funding & Grants

Comments are closed.